Should streptokinase be readministered? Insights from recent studies of antistreptokinase antibodies.
D B
DB
Cross
D000368:Aged; D000906:Antibodies / Q000097:blood; D000907:Antibodies, Bacterial / Q000097:blood*; D000937:Antigen-Antibody Reactions; D004342:Drug Hypersensitivity / Q000209:etiology; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D012008:Recurrence; D013290:Streptococcal Infections / Q000276:immunology; D013291:Streptococcus / Q000276:immunology; D013300:Streptokinase / Q000008:administration & dosage*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D000906:Antibodies; D000907:Antibodies, Bacterial; C014338:antistreptokinase; D013300:Streptokinase; D010959:Tissue Plasminogen Activator